Voyager Therapeutics (VYGR) Misses Q1 EPS by 8c

Voyager Therapeutics (NASDAQ: VYGR) reported Q1 EPS of ($0.53), $0.08 worse than the analyst estimate of ($0.45). Revenue for the quarter came in at $6.47 million versus the consensus estimate of $12.95 million.

For earnings history and earnings-related data on Voyager Therapeutics (VYGR) click here.

You May Also Be Interested In

• Texas Instruments (TXN) Reiterated at Neutral by Cantor Fitzgerald on Upside to Earnings Power
• EXL launches new brand identity, marks 20 years on Nasdaq
• Increasing unusual put volume: QQQM MPT CASY TROW SN BURL EQT VIK BRUN CAMT JMKE JXN FEZ CTAS ASO NVS